ECUR-506

N/A

Report date: 2026/01/09 10:04:36

Base Information

Drug NameECUR-506
Drug Alias NameGTP-506ECUR-506
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionOTC gene transference
TargetsOrnithine carbamoyltransferase
Therapy Area/IndicationsOrnithine Carbamoyltransferase Deficiency DiseaseUrea Cycle Disorders, Inborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesiECURE Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrecision Biosciences InciECURE Inc
Inactive CompaniesN/A
Active IndicationsOrnithine Carbamoyltransferase Deficiency DiseaseUrea Cycle Disorders, Inborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A